Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Scleritis Market Growth in 2025?
In the past few years, the scleritis market has experienced significant growth. It is predicted to expand from $3.60 billion in 2024 to $3.94 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.3%. Reasons for this historical growth include a surge in autoimmune disorders, increased understanding and consciousness of eye health, expansion in the aging population, improved availability of ophthalmic care, and global advancements in healthcare infrastructure.
What Is the Forecast for the Scleritis Market Size Through 2029?
The market for scleritis is anticipated to witness substantial growth in the years to come. It is projected to reach a value of $5.54 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.9%. The surge during the prediction period can be linked to an increase in eye-related illnesses, heightened understanding of eye health, escalating healthcare spending, broadening ophthalmology research, growing demand for customized medications, and increased treatment options. The prediction period will see dominant trends like the emergence of targeted biologic therapies, enhancements in immunosuppressive drug formulations, progress in imaging technologies, the use of minimally invasive diagnostic tools, the application of personalized medicine methods, progress in drug delivery systems, and diagnostic and treatment planning solutions powered by Artificial Intelligence.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21283&type=smp
What are the Key Market Players in Scleritis Market and How They’re Evolving?
Major companies operating in the scleritis market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceuticals USA Inc., Baxter International Inc., Boehringer Ingelheim, Regeneron Pharmaceuticals Inc., Fresenius Kabi USA LLC, Sun Pharmaceutical Industries Ltd., Perrigo Company, Horizon Therapeutics plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals, Alvogen, Accord Healthcare, West-Ward Pharmaceuticals, Jubilant Cadista Pharmaceuticals Inc., Mylan Pharmaceuticals Inc., Zydus Pharmaceuticals Inc.
What Are the Primary Growth Drivers in the Scleritis Market?
The escalation in the occurrence of autoimmune diseases is anticipated to propel the expansion of the scleritis market. These diseases are conditions in which the body’s immune system erroneously targets its own healthy cells and tissues as if they were external threats. The increase in autoimmune diseases can be attributed to factors such as genetic predispositions, environmental influences, lifestyle alterations, and enhanced cognizance, which leads to improved diagnostics. When an autoimmune disease triggers an inflammatory immune response that incorrectly attacks the scleral tissue, it results in scleritis, causing discomfort and redness. For example, Versorgungsatlas.de, a German organization, reported in November 2024 that out of 73,241,305 insured individuals in 2022, 6,304,340 had a diagnosis of at least one autoimmune disease, leading to a crude prevalence rate of 8.61%. Consequently, the increasing incidence of autoimmune diseases is fueling the expansion of the scleritis market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21283&type=smp
What Are the Leading Segments in the Global Scleritis Industry?
The scleritis market covered in this report is segmented –
1) By Type: Anterior Scleritis, Posterior Scleritis, Other Types
2) By Treatment: Medication, Surgery, Other Treatment
3) By Distribution Channel: Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channel
4) By End-Users: Hospitals, Specialty Clinics, Home Healthcare, Other End-Users
Subsegments:
1) By Anterior Scleritis: Non-Necrotizing Anterior Scleritis, Necrotizing Anterior Scleritis
2) By Posterior Scleritis: Diffuse Posterior Scleritis, Nodular Posterior Scleritis, Scleritis With Choroidal Involvement
3) By Other Types: Chronic Scleritis, Recurrent Scleritis, Infectious Scleritis
What Are the Key Market Trends in the Scleritis Industry?
Leading firms in the scleritis market are concentrating on producing cutting-edge offerings like eye drops to counteract underlying inflammation and provide practical, non-surgical treatment options to patients. Eye drops, essentially liquid solutions meant for direct application in the eyes, help alleviate symptoms such as irritation, dryness, inflammation, or infections. For instance, in May 2023, Entod Pharmaceuticals, a pharmaceutical company based in India, introduced CYCLOTEARS eye drops both in India and internationally. This groundbreaking treatment for inflammatory eye disorder utilizes the exclusive SEDDS technology, enhancing drug delivery and effectiveness. It provides an innovative solution for inflammation in DED, thereby marking noteworthy progress in the treatment of eye inflammation, ocular myositis, and scleritis.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/scleritis-global-market-report
What Is the Regional Outlook for the Scleritis Market?
North America was the largest region in the scleritis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the scleritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21283
This Report Delivers Insight On:
1. How big is the scleritis market, and how is it changing globally?
2. Who are the major companies in the scleritis market, and how are they performing?
3. What are the key opportunities and risks in the scleritis market right now?
4. Which products or customer segments are growing the most in the scleritis market?
5. What factors are helping or slowing down the growth of the scleritis market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model